Newsroom
Using Platelet-Rich Plasma (PRP) Therapy to Efficiently Reduce Beard Hair Loss
Platelet-Rich Plasma (PRP) therapy is one of the most recent scientific advancements in the field of hair restoration. It’s simple, painless and relies on activating your body’s own healing capacities. Here is what you need to know about this procedure: What is Platelet-Rich Plasma (PRP) Therapy for beard hair loss? PRP therapy has already been successfully used for some time in treating other conditions, such as muscle, bone or joint injuries. However, it was only recently that its benefits in promoting hair growth and restoration have been scientifically verified. This quick and easy procedure involves drawing a little bit of your own blood, then using a special centrifuge to separate the substances in it. Once the nutrient-rich platelets, which are great at promoting tissue growth are isolated, they are injected into the balding areas on your chin. This leads to better vascularization, tissue healing and regeneration, which means your reinvigorated follicles will start producing a thick and healthy-looking beard. The procedure is no more painful than the sting of any injection, it is not invasive and carries no more risks than your average jab. Because it is your own blood that you are using, there is no chance of the body rejecting the platelets. Who can benefit from PRP therapy for beard hair loss? There is already mounting evidence that PRP can be very effective in treating androgenetic alopecia (male pattern baldness) in the beard area. However, new research indicates that it may also successfully treat alopecia areata of the beard – a relatively rare, auto-immune condition which leaves a pattern bald spots on your chin. PRP therapy can also help treat beard loss caused by trauma (if the scarring is not too severe), by resolved skin issues, or by aging. However, it is unlikely that this procedure will yield good results if your hair loss is caused by beard trichotillomania (pulling out your beard hair when stressed), chemotherapy, untreated dermatological conditions, extensive scarring etc. If you are unsure what is causing your beard hair to fall out or would like to be certain that PRP is the right choice for you, do not hesitate to schedule an appointment with a dermatologist. How much does PRP therapy for beard hair loss cost? A good price-quality ratio, offered by the well-reputed Wimpole Clinic in London, starts at $449 per PRP session. Given that 3-4 sessions, spaced out 4 weeks apart are normally required, followed by a booster session after 6-12 months, you should probably consider setting aside around $2,000-3,000 for the procedure in the first year.
May 21, 2021
Cureus May 2021 Newsletter
Hi, Have you submitted an article to Cureus this year? So far in 2021, our average time from first submission to publication is only 38 days! Or maybe you've recently published an article - did you know you can bypass the PMC indexing embargo or purchase social media promotion? We're introducing additional purchase options so you can customize your publishing experience. Check out the details below!
May 21, 2021
Is There an Association Between Psoriasis/PsA and Thyroid Disease?
An article on the etiological association between psoriasis and thyroid diseases published in Cureus was recently picked up by RheumatologyAdvisor Read the Cureus article: The Etiological Association Between Psoriasis and Thyroid Diseases Click here to read the news story.
Apr 28, 2021
Cureus April 2021 Newsletter
Hi, Welcome back to the April edition of the Cureus Newsletter. Thank you for your continued support of our mission to eliminate barriers to the generation and dissemination of medical knowledge. Over 55% of accepted articles submitted this year have been published in three weeks or less.
Apr 15, 2021
Cureus December 2020 Newsletter
Hi, As 2020 comes to a close, we would like to thank you for your support during this very difficult year. Publishing and sharing peer-reviewed medical knowledge is more important than ever. We're on pace to publish over 5,600 peer-reviewed articles this year and that number would be zero if not for our dedicated community of authors and peer reviewers. We hope you are staying safe this holiday season! ---- As part of our continued efforts to improve the author experience, we're giving you more control over when peer review ends.
Mar 26, 2021
Cureus March 2021 Newsletter
Hi, 2021 Match Day is right around the corner. On Friday, March 19th thousands of medical students will be finding out where they'll spend their residency. In honor of this incoming group of medical residents, we're highlighting some recently published articles on the match process and medical residency. Good luck to all of you future residents out there!
Mar 12, 2021
Strategies to Promote Long-Term Cardiac Implant Site Health Publishing Competition
The Strategies to Promote Long-Term Cardiac Implant Site Health publishing competition has come to a close and we are pleased to announce the winning articles based on highest Cureus SIQ score*! 1st place (8.54 SIQ) - $5,000 honorarium: 'Strategies to Promote Long-Term Cardiac Implant Site Health' by Taleski and Zafirovska 2nd place (8.39 SIQ) - $2,000 honorarium: 'Evidence-Based Strategies to Promote Long-Term Cardiac Implant Site Health: Review of the Literature' by Licari, Viola, Carolla, Campanella and Salamone 3rd place (8.16 SIQ) - $1,000 honorarium: 'Surgical Techniques, Complications, and Long-Term Health Effects of Cardiac Implantable Electronic Devices' by Richardson, Prempeh, Gordon, Poyser and Tiesenga Congratulations to the winning authors - we'll be contacting each submitting author to arrange for honorarium delivery, which includes the option of a cash distribution or equivalent donation made to the charity of their choice. We'd also like to thank the Cureus community and our sponsor, Aziyo Biologics, for making this competition a success. You can browse through the entire library of competition articles via the link below. https://www.cureus.com/competitions/cardimplanthealth
Mar 05, 2021
Research into Covid-19 Induced Blindness
An article published in Cureus regarding cortical blindness following Posterior Reversible Encephalopathy Syndrome (PRES) as a complication of COVID-19 Pneumonia was recently picked up by Punch Healthwise, Prompt News Online, Urdu Point News, Sputnik News, and World Stage. Read the Cureus article here: Persistent Cortical Blindness Following Posterior Reversible Encephalopathy Syndrome (PRES) as a Complication of COVID-19 Pneumonia
Feb 19, 2021
The Flu Vaccination, COVID-19, and the Pediatric Population
An article on the effect of the flu vaccination on the pediatric population published in Cureus was picked up by WebMD.com Read the Cureus article here: The Flu Vaccination May Have a Protective Effect on the Course of COVID-19 in the Pediatric Population: When Does Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Meet Influenza?
Feb 11, 2021
Cureus January 2021 Newsletter
Hi, We did it - 2020 is finally over. We don't need to list the reasons why it was such a challenging year - you know them just as well as we do. Before we close the book on this tumultuous year, we want to take a moment to review our growth as a journal as well as the many improvements made by our tireless team. 2020 was indeed the biggest year yet for Cureus, but we want to emphasize that none of this would've been possible without your support. The Cureus community of clinicians, researchers and interested readers has grown significantly over the past few years and we take seriously our responsibility to provide each and every one of you with a quality experience. Thank you for your support! Cureus 2020 in Review
Jan 29, 2021
